NDC11 71921040521
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71921-0405-21 | 71921-0405 |
| 71921-405-21 | 71921-405 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| rivaroxaban | RIVAROXABAN | Florida Pharmaceutical Products, LLC | f0ef9361-f06d-4028-97af-183b545f4aea | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | 71921-405-21 71921-405 71921040521 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.